Trial Profile
A Phase IIa Study for the Treatment of HIV Patients Already in Antiretroviral Therapy (ART) and where this Therapy is Postponed After a Time of Combined Treatment with GnRH Agonist (ISR48)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Apr 2018 New trial record